Glaxo Wellcome Purchases Genomica s Bioinformatics Package After Beta Test | GenomeWeb

BOULDER, Colo.--Genomica has sold the first US license for its Discovery Manager bioinformatics application to Glaxo Wellcome. The sale closely followed Genomica's first ever license sale, to Oxagen in Oxford, UK.

Thomas Marr, president and CEO of Genomica, noted, "This is the first big pharmaceutical company, so it is very exciting." He said Glaxo's genetics department had been beta-testing Discovery Manager. When the test ended, Glaxo decided to buy the software.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.